Pharmaceutical Investing Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat
Pharmaceutical Investing FDA Grants Rare Pediatric Disease Designation to A4250; Albireo Eligible to Apply for Priority Review Voucher
Noble Mineral highlights Successful Exploration Results announced by Canada Nickel, including Highest Grade to Date at Mann West
